BANK OF MONTREAL /CAN/ - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$109,000
+67.7%
3,184
-24.6%
0.00%
Q2 2020$65,000
+828.6%
4,221
+744.2%
0.00%
Q1 2020$7,000
-96.9%
500
-92.7%
0.00%
Q4 2019$228,000
+121.4%
6,822
+39.3%
0.00%
Q3 2019$103,000
+14.4%
4,897
+12.2%
0.00%
Q2 2019$90,000
+309.1%
4,363
+336.3%
0.00%
Q1 2019$22,000
-40.5%
1,000
-34.0%
0.00%
Q4 2018$37,000
+32.1%
1,516
+47.9%
0.00%
Q3 2018$28,000
-39.1%
1,025
-40.9%
0.00%
Q2 2018$46,000
+2.2%
1,734
+23.9%
0.00%
Q1 2018$45,000
-15.1%
1,4000.0%0.00%
Q4 2017$53,0001,4000.00%
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders